GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome
Author(s) -
Liron Danielpur,
YangSung Sohn,
Ola Karmi,
Chen Fogel,
Adar Zinger,
Abdulsalam AbuLibdeh,
Tal Israeli,
Yael Riahi,
Orit Pappo,
Ruth Birk,
David Zangen,
Ron Mittler,
Zvi-Ioav Cabantchik,
Erol Cerasi,
Rachel Nechushtai,
Gil Leibowitz
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2240
Subject(s) - endocrinology , medicine , insulin , mitochondrion , type 2 diabetes , chemistry , exenatide , insulin resistance , context (archaeology) , diabetes mellitus , biology , biochemistry , paleontology
Type 2 Wolfram syndrome (T2-WFS) is a neuronal and β-cell degenerative disorder caused by mutations in the CISD2 gene. The mechanisms underlying β-cell dysfunction in T2-WFS are not known, and treatments that effectively improve diabetes in this context are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom